Home › Compare › SHTDF vs QYLD

SHTDF vs QYLD: Dividend Comparison 2026

SHTDF yields 3.51% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHTDF wins by $3.9K in total portfolio value
10 years
SHTDF
SHTDF
● Live price
3.51%
Share price
$2.68
Annual div
$0.09
5Y div CAGR
9.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$1,273.49
Full SHTDF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — SHTDF vs QYLD

📍 SHTDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHTDFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHTDF + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SHTDF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHTDF
Annual income on $10K today (after 15% tax)
$298.49/yr
After 10yr DRIP, annual income (after tax)
$1,082.47/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, QYLD beats the other by $3,727.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHTDF + QYLD for your $10,000?

SHTDF: 50%QYLD: 50%
100% QYLD50/50100% SHTDF
Portfolio after 10yr
$27.3K
Annual income
$3,466.40/yr
Blended yield
12.68%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHTDF buys
0
QYLD buys
0
No recent congressional trades found for SHTDF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHTDFQYLD
Forward yield3.51%11.92% ✓
Annual dividend / share$0.09$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.8% ✓0%
Portfolio after 10y$29.3K ✓$25.4K
Annual income after 10y$1,273.49$5,659.31 ✓
Total dividends collected$7.5K$27.1K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SHTDF vs QYLD ($10,000, DRIP)

YearSHTDF PortfolioSHTDF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$11,086$385.58$10,352$1,192.36+$734.00 → SHTDF
2$12,300$438.62$10,830$1,347.57+$1.5K → SHTDF
3$13,661$499.41$11,460$1,539.07+$2.2K → SHTDF
4$15,186$569.16$12,275$1,777.84+$2.9K → SHTDF
5$16,898$649.28$13,323$2,078.95+$3.6K → SHTDF
6$18,823$741.39$14,667$2,463.34+$4.2K → SHTDF
7$20,988$847.43$16,396$2,960.57+$4.6K → SHTDF
8$23,426$969.62$18,631$3,612.97+$4.8K → SHTDF
9$26,177$1,110.62$21,548$4,482.15+$4.6K → SHTDF
10$29,283$1,273.49$25,398$5,659.31+$3.9K → SHTDF

SHTDF vs QYLD: Complete Analysis 2026

SHTDF — Stock

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Full SHTDF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this SHTDF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHTDF vs SCHDSHTDF vs JEPISHTDF vs OSHTDF vs KOSHTDF vs MAINSHTDF vs XYLDSHTDF vs JEPQSHTDF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.